Lijun Wu

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Ankylosing Spondylitis

Top Venues

Lupus science & medicine

Rheumatology and immunology research

Clinical rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Liling Zhao, Wenwen Wang, Lijun Wu, Tong Wu, Jianxin Tu, Xue Wu, Fangfang Sun, Huihua Ding, Nan Shen, Huaxiang Wu, Jing Zhu, Li Sun, Shuang Ye
Combination of anti-SSA/Ro60 and anti-dsDNA serotype is predictive of belimumab renal response in patients with lupus nephritis. Lupus science & medicine 11 (1) (2024)
Liling Zhao, Wenwen Wang, Lijun Wu, Tong Wu, Jianxin Tu, Xue Wu, Fangfang Sun, Huihua Ding, Nan Shen, Huaxiang Wu, Jing Zhu, Li Sun, Shuang Ye
Combination of anti-SSA/Ro60 and anti-dsDNA serotype is predictive of belimumab renal response in patients with lupus nephritis. Lupus science & medicine 11 (1) (2024)
Liling Zhao, Wenwen Wang, Lijun Wu, Tong Wu, Jianxin Tu, Xue Wu, Fangfang Sun, Huihua Ding, Nan Shen, Huaxiang Wu, Jing Zhu, Li Sun, Shuang Ye
Combination of anti-SSA/Ro60 and anti-dsDNA serotype is predictive of belimumab renal response in patients with lupus nephritis. Lupus science & medicine 11 (1) (2024)
Liling Zhao, Wenwen Wang, Lijun Wu, Tong Wu, Jianxin Tu, Xue Wu, Fangfang Sun, Huihua Ding, Nan Shen, Huaxiang Wu, Jing Zhu, Li Sun, Shuang Ye
Combination of anti-SSA/Ro60 and anti-dsDNA serotype is predictive of belimumab renal response in patients with lupus nephritis. Lupus science & medicine 11 (1) (2024)
Yi Chen, Xue Wu, Xiaomei Chen, Mengmeng Li, Cainan Luo, Yamei Shi, Jing Li, Lijun Wu
Correlations of baseline neutrophil-lymphocyte ratio with prognosis of patients with lupus nephritis: A single-center experience. Rheumatology and immunology research 4 (4) (2023)
Yi Chen, Xue Wu, Xiaomei Chen, Mengmeng Li, Cainan Luo, Yamei Shi, Jing Li, Lijun Wu
Correlations of baseline neutrophil-lymphocyte ratio with prognosis of patients with lupus nephritis: A single-center experience. Rheumatology and immunology research 4 (4) (2023)
Jia Li, Zhixin Xue, Zhen-Biao Wu, Liqi Bi, Huaxiang Liu, Lijun Wu, Shengyun Liu, Xiangyang Huang, Yong Wang, Yan Zhang, Wufang Qi, Lan He, Lie Dai, Lingyun Sun, Xiao-Mei Li, Zongwen Shuai, Yi Zhao, Yanyan Wang, Jian Xu, Hao Zhang, Hao Yu, Xiaoxiang Chen, Chunde Bao
Comparison of the efficacy and safety of the adalimumab biosimilar TQ-Z2301 and adalimumab for the treatment of Chinese patients with active ankylosing spondylitis: a multi-center, randomized, double-blind, phase III clinical trial. Clinical rheumatology 41 (10) (2022)